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ABSTRACT
Background and Objective: According to the fact that neonatal infection is a challenging 
diagnosis ﬁeld, several studies have tried to test sensitivity and speciﬁcity of diagnostic tests. This 
study was conducted to evaluate the sensitivity and speciﬁcity of procalcitonin (PCT) as a single 
early marker of neonatal sepsis.
Materials and Methods: In this study, 150 neonates admitted to NICU and neonatal ward in 
Shahrekord Hajar hospital were enrolled. A full workup including blood cultureand other tests and 
PCT was conductede. Sensitivity, speciﬁcity, positive and negative predictive values for PCT was 
determined.
Results: It was found out that 8 patients had deﬁnite infection, 15 patients had possible infection, 
and 127 patients had no infection. Although PCT was not able to signiﬁcantly differentiate 
between those with deﬁnite and possible infections (p>0.05), but there was a signiﬁcant difference 
for frequency of abnormal PCT between non-infectious patients and other patients. Sensitivity, 
speciﬁcity, positive and negative predictive values of PCT was 87.5%, 87.4%, 30.4%, 99.1%, and 
87.41% respectively.
Conclusion: Beside the limitation of the sample size, the satisfactory diagnostic characteristics 
of PCT highlight it as a good measure for diagnosis of neonatal sepsis. Further studies are essential 
to be carried out.
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Introduction
Neonatal sepsis has been one of the major diagnostic problems for physicians due to 
non-speciﬁcity of its symptoms and the absence 
of a reliable Para clinical marker. This condition is 
clinically important since it is one of the main causes 
of mortality in infants, especially those with a low 
at-birth weight (1). Mortality rate for neonatal sepsis 
has been reported as 10-50% (2). Therefore, it’s fast 
and on time diagnosis could lower mortality rate in 
infants (3). Diagnosis of neonatal sepsis using clinical 
symptoms is not possible (1). Although isolating its 
responsible microorganisms using blood culture has 
been the golden standard method for its diagnosis (4), 
but its result is ready 24-72 h after sampling and during 
this time period it is necessary to treat suspicious 
infants for sepsis with antibiotics according to 
clinical symptoms and risk factors. It is also possible 
that a pseudo-negative result is obtained in some 
cases (1;4). The present trend applied for infants 
suspicious of neonatal sepsis may lead to unnecessary 
increased antibiotic consumption, a higher incidence 
of side-effects due to their use, increased resistance to 
antibiotics, a long hospitalization, and separation of 
infants from their mothers and increased health costs 
(5;6). 
Therefore, using fast diagnostic methods including 
laboratory markers could be beneﬁcial in diagnosis 
of neonatal sepsis. In addition to blood culture, other 
tests that are usually used for diagnosis of neonatal 
sepsis include complete blood count and acute phase 
protein (CRP). Unfortunately, these tests do not have 
a high sensitivity and speciﬁcity. Meanwhile, some 
studies have shown that CRP has a limited use in 
diagnosis of neonatal infections (3;7). 
Recently, serum procalcitonin (PCT) has been 
reported as a measurable laboratory marker in 
inﬂammatory response to infection in some studies. 
This factor is the preformed of calcitonin that although 
is not measurable in serum of normal individuals, 
but its titer increases during microbial, fungal, and 
parasitic infections (8). The goal of this study was to 
evaluate PCT level in infants with sepsis and to assess 
its diagnostic value.
Materials and Methods
This study had a descriptive-analytical strategy and 
was conducted on suspicious infants to have sepsis 
and hospitalized in infants ward and intensive care 
unit of Hajar hospital (Shahrekord) from 2006 to 2007. 
Those infants treated for sepsis were hospitalized 
with 2-3 symptoms of sepsis in addition to one of the 
maternal and infantile risk factors. 
Clinical criteria for diagnosis of sepsis were as 
follows: 1) maternal risk factors including fever, use 
of alcoholic beverages, premature rupture of water 
sac (PROM) greater than 24 h, chorioamnionitis, and 
urinary tract infection (9), 2) neonatal risk factors 
including low birth-time weight (less than 2500 
g) and still birth (less than 37 weeks) (9), and 3) 
clinical symptoms and signs of sepsis including loss 
of appetite, changes in body temperature (fever and 
hypothermia), jaundice, apnea, respiratory distress, 
tachycardia, tachypnea, cyanosis, and vomiting (9).
Before initiating venous antibiotic treatment, blood 
sampling was ordered by responsible physician 
for routine tests to diagnose neonatal sepsis. 
Simultaneously, 2 ml of clotted blood was sent to 
laboratory for determination of PCT level. After 
centrifugalization and its serum isolation, it was kept 
at – 70 °C. 
After determination of results for complete cell 
count, CRP, and blood culture, the infants were 
grouped within the following three groups: group 
(1) those infants with positive blood culture and 
CRP and more than two clinical symptoms (8 cases), 
group (2) those cases with negative blood culture, 
positive CRP, and more than two clinical symptoms 
(15 cases), and group (3) infants with negative blood 
culture and CRP and more than two clinical symptoms 
(127 cases). CRP measurement was done according 
to latex agglutination method. In addition, PCT 
measurement was performed after collection of 150 
serum samples. For this purpose, PCT-G kit (Brahms, 
Germany) was used. The related samples for PCT 
measurement were exposed to room temperature 
(immunology laboratory) 30 min before assay. The 
basis for this assay was an immunochromatographic 
one that is considered a semi-quantitative method for 
measurement of PCT. The kits were removed from their 
packages immediately before use and 200-microliter 
sampler was used for sample taking and to pour it on 
labeled round part of the kit chromatographic paper. 
This paper had also two other parts including control 
and test bands. The latter band turned pink or red if 
any PCT exist in case serum and its color intensity was 
closer to control band if level of PCT was higher. Each 
kit had also a reference card for recording test results. 
Meanwhile, three colors as weak pink, intense pink 
and red were indicative as different concentration of 
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PCT in serum. In this respect, red, intense, and week 
pink colors were indicative of a PCT level equal or 
greater than 10 ng/ml, greater than 2 ng/ml, and 0.5 
ng/ml respectively. 
The results of studies on normal infants have shown 
that during the ﬁrst 48 h of lifetime, a PCT level of 
2 ng/ml is normal (10). In our study, a PCT level 
higher than 2 ng/ml during the ﬁrst 48 h and a PCT 
level greater than 0.5 ng/ml after that time considered 
abnormal (11;12). 
For blood culture, a biphasic medium was used. 
In this regard, 1-3 ml of blood was added to culture 
medium and incubated for 5 days at 25 °C. Culture 
media were daily evaluated with respect to turbidity 
and bacteria growth and in condition of such growth; 
special media was used for passage to determine its 
type and sensitivity to antibiotics. 
For inclusion in the study, a written consent was 
taken from their mothers. In addition, infants with a 
low blood calcium or glucose level during the study 
were excluded. For data analysis, SPSS software 
was used. Meanwhile, blood culture was regarded as 
the golden standard method and for other tests their 
diagnostic attributes were compared to the standard 
one. In this way, speciﬁcity, and positive and negative 
predictive values for PCT as a marker for neonatal 
sepsis was reported.
Results
In this study, 150 infants suspected of sepsis were 
evaluated. In this respect, 93 cases (62%) were boy. 
Time of ﬁrst clinical symptoms in 60 cases (40%) 
was within the ﬁrst 48 h after birth and in others it 
was after this period. Weight average of infants was 
2670 ± 637 g. In addition, 49 infants (32.7%) were 
premature. Meanwhile, 41 (27.3%), 62 (41.3%) and 
47 (31.3%) out of cases had a good, intermediate, 
and weak infantile reﬂex responses respectively. Data 
for range, average, and standard deviation of blood 
glucose and calcium levels, WBC, neutrophil, and 
lymphocyte counts have been presented in Table 1
Abolfazl Khoshdel, et al
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Table 1: Laboratory ﬁndings in neonates suspicious to neonatal sepsis
Mean + SDrangeLaboratory ﬁndings
87.8 + 50.540 – 397Serum glucose (mg/dl)
1.2 + 9.67.5 – 13Serum calcium (mg/dl)
9.4 + 134 – 73.4White blood cell count(Number/μl)
16.1 + 41.510 - 81Neutrophil %
50 + 16.83.1 – 85.5Lymphocyte %
Furthermore, CRP measurement was done at the 
time of hospitalization before treatment. In this 
regard, it was positive in 20 cases. The most prevalent 
pathogen in blood culture was Klebsiella. Serum 
level of PCT in group 1 (those infants with positive 
blood culture and CRP and more than two clinical 
symptoms) was positive in 87.5% of cases. Serum 
level of PCT in group 2 (those cases with negative 
blood culture, positive CRP, and more than two 
clinical symptoms) was positive in 12.6% of cases. 
Serum level of PCT in group 3 (infants with negative 
blood culture and CRP and more than two clinical 
symptoms) was positive in 20% of cases. In addition, 
there was a statistically signiﬁcant difference between 
group 3 and the other two groups, i.e. PCT in group 
3 was lower as compared to groups 1 and 2 (p<0.05). 
Meanwhile, with regard to blood culture as a golden 
standard method, sensitivity, speciﬁcity, and positive 
and negative predictive values of PCT level for 
neonatal sepsis was 87.5%, 87.4%, 30.4%, and 99.1% 
respectively. Table 2 shows distribution frequencies 
for positive and negative PCT in different groups and 
their diagnostic attributes. 
Table 2: Positive and negative PCT in different groups
TotalDeﬁnite infectionSuspicious to infectionNo infectionGroups
124112111Negative
267316Positive
150815127Total
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Discussion
The results of the present study showed that 
sensitivity, speciﬁcity, and positive and negative 
predictive values of PCT level for neonatal sepsis was 
87.5%, 87.4%, 30.4%, and 99.1% respectively. With 
regard to the turning point of 2 ng/dl, this level of 
sensitivity and speciﬁcity is appropriate. 
According to other studies, PCT is suitable for 
diagnosis and evaluation of response to treatment 
in neonatal infection (10;13). Some studies have 
reported a higher sensitivity for this marker in early 
stages of neonatal infection in comparison with acute 
phase protein (CRP) (14). In another study, a negative 
predictive value of 95% has been obtained for PCT 
(15). Monneret et al conducted a study in Stockholm 
on 94 infants hospitalized in ICU and found that PCT 
level increases more rapidly in neonatal infection 
than acute phase C protein (CRP) and its level also 
decreases more rapidly after successful treatment. 
PCT level increases 3-4 h after exposure to bacterial 
agents and within 6 h, it reaches to maximum level, 
while CRP increase requires 12-18 h (15). In a study 
by Chiesa et al in Italy on 120 infants hospitalized 
in neonatal ICU and 83 normal neonates, the cases 
were divided into non-infectious (control), suspected 
of infection with clinical symptoms, and infectious 
with a positive blood culture groups. In this regard, 
sensitivity and speciﬁcity for increased serum level of 
PCT during the ﬁrst 48 h after birth were determined 
as 99.6% and 97.5% in infectious groups respectively 
and they were 100% in control group (11). In another 
study by Chiesa et al, sensitivity for PCT in diagnosis 
of neonatal sepsis in early measurement was obtained 
as 85.7% (3). PCT also completely predicted infection 
in 89.5% of cases (16). 
In this study, 34.7% of suspected patients for 
infection were diagnosed as having infection 
following a positive blood culture. This ﬁgure was 
10% in Vali-Asr hospital (Tehran) in 1999 (17), 
11% in Moﬁd hospital (Tehran) from 1997 to 1998 
(18), 41% in Ali-Asghar hospital in 1997 (19), and 
16.8% in Ghaem hospital (Hamedan) from 1997 to 
1998 (20;21). The results of our study showed that 
incidence of true septic infection in suspected infants 
is low and many of them with no signs of infection 
are treated with antibiotics. In addition, although the 
most prevalent pathogen responsible for neonatal 
infection in our study was Klebsiella, in other studies 
conducted in our country it has been Staphylococcus 
coagulase positive and negative and Klebsiella (22), 
Pseudomonas and Klebsiella (23), Gram-negative 
and non-fermentative Bacilli and Klebsiella (15), 
Staphylococcus epidermis and Enterobacter (19). 
Since type of prevalent pathogen differs in 
different studies and with regard to the fact that PCT 
positivity is lower in infections with low virulence 
microorganisms (14), therefore, sensitivity and 
speciﬁcity will be different in various studies and 
under different conditions. It is noteworthy that in 
some studies the turning point has been regarded 
as 0.5 ng/dl (24) and it has been as 2 ng/dl (10) in 
other studies. In our study, all cases of group 1 with 
abnormal PCT showed a lower PCT after antibiotic 
treatment up to the extent that was unmeasurable. In 
Chiesa et al study in 2003, PCT was used as an index 
for treatment follow up and duration (12).  
In the present study, only cases with a deﬁnite 
infection (blood culture positive) were included for 
determination of PCT sensitivity and speciﬁcity and 
hence sample size was relatively small, but since 
there have been limited studies in this ﬁeld in our 
country, it was necessary to report these data. Since 
PCT was not capable to differentiate suspected cases 
of infection from control cases, it is not of much value 
in diagnosis of possible infection without the presence 
of a positive blood culture. However, its sensitivity in 
diagnosis of deﬁnite and possible cases of infection 
is 56.5% and its negative predictive value in these 
groups is 90%.
Conclusion
With regard to the results of the present study and high 
negative predictive value of PCT, it is recommended 
that PCT test is conducted at the time of or before 
hospitalization to evaluate possible sepsis. In PCT-
negative cases, there is certainly a negative blood 
culture that could lower hospitalization period and in 
this way to compensate for its high cost. However, 
cost-beneﬁt studies are warranted to be conducted. Its 
high cost is still a negative factor for its clinical and 
routine application.
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